Latest filing published 28 Aug 2009 for Emmaus Life Sciences, Inc..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
David B. Jones: trading record in brief
All filings by David B. Jones on record concern Emmaus Life Sciences, Inc. We count 4 filings; the first trade dates from 30 June 2009 and the latest from 26 August 2009.
Purchases make up the whole of the open-market record (1 purchase, €225k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 1 share grant.
The record was last updated on 28 August 2009 with an open-market purchase (€225k) in Emmaus Life Sciences, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to David B. Jones
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 956,164 sharesCommon StockSEC:0001170918-09-000368:0
- 802,192 sharesCommon StockSEC:0001170918-09-000368:1
2 of 2 declarations